Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT05738083Recruiting

Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH

Role: collaborator

NCT07318948Not ApplicableNot Yet Recruiting

BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Role: collaborator

NCT06898216Not ApplicableRecruiting

Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial

Role: collaborator

NCT05206890Recruiting

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

Role: collaborator

NCT02887963Completed

Epidemiological Study of Iron Deficiency and Iron Deficiency Anemia in Chinese Pregnant Women

Role: collaborator

All 6 trials loaded